Microfluidic Chip Sorting Nucleic Acids via Dielectrophoresis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are inadequate for identifying and measuring viruses in clinical or environmental samples, as many viruses cannot be cultured, leading to challenges in phenotypic characterization and detection, especially with rapid genetic evolution and limited knowledge of viral backgrounds in environmental, human, and agricultural samples.
Innovation Solution
A chip-based system for parallel nucleic acid sorting, amplification, and characterization using microdroplet polymerase chain reaction (PCR) followed by capillary electrophoresis analysis, allowing for the detection and sequencing of unknown genetic material, with a planar substrate divided into cells with electrodes for manipulating micro-reactors and a detector for interrogation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional phenotypic characterization methods are used for virus identification, then cultural methods can identify some viruses, but many viruses cannot be cultured making identification impossible
Solution Approach 1:
The patent replaces traditional mechanical/cultural methods with a microfluidic digital PCR system that uses electrical fields and thermal cycling to amplify and detect viral genetic material directly from samples, eliminating the need for virus cultivation while enabling identification of any virus with known genetic sequences
Solution Approach 2:
The system changes the detection parameter from phenotypic characteristics (requiring culture) to genotypic characteristics (detectable via PCR), allowing identification of viruses based on their genetic material rather than their physical growth properties
2Reliability
If conventional PCR and analysis methods are used, then nucleic acid amplification can be performed, but reagent volumes are large and costs are high
Solution Approach 1:
The patent segments the sample into numerous individual picoliter-sized droplets, each containing a minimal amount of reagents for PCR amplification. This segmentation allows parallel processing of many samples simultaneously while using extremely small reagent volumes in each reaction, dramatically reducing total reagent consumption and cost
Solution Approach 2:
The system transitions from single large-volume reactions to thousands of parallel micro-volume reactions, adding the dimension of parallelism to achieve both high reliability through multiple replicates and low reagent consumption through miniaturization
3Extent of automation
If robotic-based systems are used for sample analysis, then automation is achieved, but device complexity and cost increase significantly
Solution Approach 1:
The patent merges multiple functions (sample dispensing, droplet generation, PCR amplification, thermal cycling, and detection) into a single integrated microfluidic chip system, eliminating the need for separate robotic manipulators, auto-pipettes, and analysis equipment while maintaining full automation
Solution Approach 2:
The microfluidic chip serves multiple functions simultaneously - it acts as a reaction vessel, thermal cycler, and detection platform, providing a universal solution that replaces multiple specialized devices and simplifies the overall system architecture
4Measurement precision
If comprehensive viral metagenomics is performed to profile unknown viruses, then detection capability is improved, but the lack of conserved sequences and genetic diversity makes profiling difficult
Solution Approach 1:
The system changes the detection approach from relying on conserved sequences to using degenerate primers that can bind to diverse viral sequences, and from phenotypic detection to direct genetic material amplification, enabling detection of novel pathogens with unknown sequences
Solution Approach 2:
The patent uses excessive amplification cycles in the digital PCR process to ensure that even single copies of novel viral genetic material are amplified to detectable levels, compensating for the lack of prior sequence knowledge and enabling detection of extremely low-abundance novel pathogens
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables efficient and cost-effective analysis of complex samples, reducing reagent volumes, and enabling scalable mass production of microfluidic chips for biowarfare detection, infectious disease monitoring, forensic analysis, and food safety testing, while supporting high-throughput genetic screening.
Implementation Method 1
Electrodes are located in the cells. A microprocessor is connected to the electrodes for manipulating the micro-reactors on the planar substrate
Implementation Method 2
A micro-reactor maker produces micro-reactors containing the sample. The micro-reactor maker is positioned to deliver the micro-reactors to the planar substrate
Implementation Method 3
Electrodes are located in the cells. A microprocessor is connected to the electrodes for manipulating the micro-reactors on the planar substrate
Data Source
AI summary
An apparatus for chip-based sorting, amplification, detection, and identification of a sample having a planar substrate. The planar substrate is divided into cells. The cells are arranged on the planar substrate in rows and columns. Electrodes are located in the cells. A micro-reactor maker produces micro-reactors containing the sample. The micro-reactor maker is positioned to deliver the micro-reactors to the planar substrate. A microprocessor is connected to the electrodes for manipulating the micro-reactors on the planar substrate. A detector is positioned to interrogate the sample contained in the micro-reactors.